MAPT and Alzheimer disease: Moreover, one cross-sectional 18F-flortaucipir PET study in Aβ+ MCI and AD patients demonstrated that the ε4− group conversely exhibited greater tau burden in the parieto-occipital cortex than the ε4+ group [18].